Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chemotherapy-Related Cognitive Impairment × Tobacco Use Cessation Devices × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Smoking Cessation 1 Neoplasms, Second Primary 1 Hand-Foot Syndrome 1 Cigarette Smoking 1 Chemotherapy-Related Cognitive Impairment 1 Behavior, Addictive 1

Interventions

Tobacco Use Cessation Devices 1 Sodium Chloride 1 Mesna 1 Electroacupuncture 1 Doxorubicin 1 Cyclophosphamide 1 Ashwagandha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02312934 2020-01-21

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Vanderbilt University Medical Center

Phase 2 Completed

22 enrolled 14 charts

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡